Borgå O, Larsson R, Lunell E
Eur J Clin Pharmacol. 1986;30(2):221-3. doi: 10.1007/BF00614308.
Enprofylline 1 mg/kg, a new potent antiasthmatic xanthine derivative, which is mainly eliminated by renal excretion, was given intravenously to 6 normal subjects with and without oral pretreatment with 1 g probenecid. The latter caused a drop in the average total body clearance of enprofylline from 21 to 9.8 l/h, and in the average renal clearance from 17 to 8.0 l/h. The average half-life increased from 1.8 to 3.0 h. The volumes of distribution, Vz and Vss, both fell by about 25%, indicating that probenecid had restricted the distribution of enprofylline in the body. The plasma protein binding of enprofylline was not altered by probenecid. The results confirm the opinion that active tubular secretion accounts for a large proportion of the total elimination of enprofylline.
恩丙茶碱,一种新型强效抗哮喘黄嘌呤衍生物,主要通过肾脏排泄消除,对6名正常受试者进行静脉给药,其中部分受试者在静脉给药前口服1g丙磺舒。丙磺舒使恩丙茶碱的平均总体清除率从21 l/h降至9.8 l/h,平均肾脏清除率从17 l/h降至8.0 l/h。平均半衰期从1.8小时增加到3.0小时。分布容积Vz和Vss均下降约25%,表明丙磺舒限制了恩丙茶碱在体内的分布。丙磺舒未改变恩丙茶碱的血浆蛋白结合率。结果证实了以下观点,即肾小管主动分泌在恩丙茶碱的总消除中占很大比例。